Beijing Shangdi Xinshiji Biological Medicine Research Institute Co., Ltd.

The pharmacokinetic characteristics of the test preparation anagrelide hydrochloride capsules were investigated after a single oral administration on an empty stomach or after a meal in healthy adult Chinese subjects. A two-period, two-crossover design was used to conduct a human bioequivalence study using the marketed anagrelide hydrochloride capsules as the reference preparation, and the safety of the test preparation and the reference preparation in healthy subjects was observed.

The purpose of this study is to investigate the pharmacokinetics of anagrelide hydrochloride capsules in healthy subjects.

To evaluate the efficacy and safety of anagrelide hydrochloride capsules in the treatment of essential thrombocythemia.